ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,527,000 | +89.9% | 32,963 | 0.0% | 0.01% | +80.0% |
| Q1 2019 | $804,000 | +71.1% | 32,963 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $470,000 | -6.2% | 32,963 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $501,000 | -9.4% | 32,963 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $553,000 | +2.8% | 32,963 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $538,000 | +12.1% | 32,963 | -12.1% | 0.00% | +33.3% |
| Q4 2017 | $480,000 | +4.1% | 37,504 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $461,000 | +46.8% | 37,504 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $314,000 | -6.3% | 37,504 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $335,000 | -1.8% | 37,504 | -3.3% | 0.00% | 0.0% |
| Q4 2016 | $341,000 | +30.2% | 38,785 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $262,000 | +89.9% | 38,785 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $138,000 | +21.1% | 38,785 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $114,000 | -14.9% | 38,785 | +22.4% | 0.00% | 0.0% |
| Q4 2015 | $134,000 | -7.6% | 31,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $145,000 | -36.7% | 31,700 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $229,000 | -2.1% | 31,700 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $234,000 | +56.0% | 31,700 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $150,000 | +32.7% | 31,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $113,000 | -22.1% | 31,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $145,000 | -2.7% | 31,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $149,000 | -6.3% | 31,700 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $159,000 | -19.3% | 31,700 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $197,000 | +36.8% | 31,700 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $144,000 | – | 31,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |